Anbio Biotechnology (NNNN) Invested Capital (2023 - 2025)

Anbio Biotechnology's Invested Capital history runs 3 years deep, the most recent figure standing at $30.2 million for Q4 2025.

• In Q4 2025, Invested Capital rose 75.41% year-over-year to $30.2 million; the TTM figure through Dec 2025 stood at $30.2 million (up 75.41% YoY), while the FY2025 annual figure was $30.2 million, up 75.41% from the prior year.
• Invested Capital was $30.2 million for Q4 2025 at Anbio Biotechnology, up from $17.2 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $30.2 million in Q4 2025 to a low of $14.8 million in Q4 2023.
• Historically, Invested Capital has averaged $20.7 million across 3 years, with a median of $17.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Invested Capital grew 16.01% in 2024, then soared 75.41% in 2025.
• A 3-year view of Invested Capital shows it stood at $14.8 million in 2023, then advanced by 16.01% to $17.2 million in 2024, then jumped by 75.41% to $30.2 million in 2025.
• The last three Invested Capital figures came in at $30.2 million (Q4 2025), $17.2 million (Q4 2024), and $14.8 million (Q4 2023), per Business Quant data.